Pembrolizumab (KEYTRUDA®) significantly prolonged Overall Survival and progression-free Survival in Patients with metastatic non-small cell Lung Cancer without Squamous Epithelium-Histology

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [1] Increasing progression-free survival in non-small cell lung cancer
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (09) : 498 - 498
  • [2] Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab
    Das, P.
    Zhao, S.
    Wei, L.
    Miah, A.
    Li, M.
    Lopez, G.
    Patel, S.
    Johns, A.
    Grogan, M.
    Bertino, E.
    He, K.
    Shields, P.
    Carbone, D.
    Otterson, G.
    Presley, C.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S293 - S293
  • [3] RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL
    Imai, Hisao
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    RESPIROLOGY, 2013, 18 : 85 - 85
  • [4] Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
    Komaki, Ritsuko
    Allen, Pamela K.
    Wei, Xiong
    Blumenschein, George R.
    Tang, Ximing
    Lee, J. Jack
    Welsh, James W.
    Wistuba, Ignacio I.
    Liu, Diane D.
    Hong, Waun Ki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 317 - 324
  • [5] Meta-analysis of progression-free survival as a predictor of overall survival in locally advanced or metastatic non-small cell lung cancer trials.
    Turner, Evadne Jane
    McCloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Individual-level data on the relationships of progression-free survival, post-progression survival and tumor response with overall survival in patients with advanced non-squamous non-small cell lung cancer
    Imai, H.
    Takahashi, T.
    Mori, K.
    Ono, A.
    Akamatsu, H.
    Shukuya, T.
    Taira, T.
    Kenmotsu, H.
    Naito, T.
    Murakami, H.
    Endo, M.
    Nakajima, T.
    Yamamoto, N.
    NEOPLASMA, 2014, 61 (02) : 233 - 240
  • [7] Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
    Takaya Yamamoto
    Yoko Tsukita
    Yu Katagiri
    Haruo Matsushita
    Rei Umezawa
    Yojiro Ishikawa
    Noriyoshi Takahashi
    Yu Suzuki
    Kazuya Takeda
    Eisaku Miyauchi
    Ryota Saito
    Yoshiyuki Katsuta
    Noriyuki Kadoya
    Keiichi Jingu
    BMC Cancer, 22
  • [8] Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
    Yamamoto, Takaya
    Tsukita, Yoko
    Katagiri, Yu
    Matsushita, Haruo
    Umezawa, Rei
    Ishikawa, Yojiro
    Takahashi, Noriyoshi
    Suzuki, Yu
    Takeda, Kazuya
    Miyauchi, Eisaku
    Saito, Ryota
    Katsuta, Yoshiyuki
    Kadoya, Noriyuki
    Jingu, Keiichi
    BMC CANCER, 2022, 22 (01)
  • [9] An FDA analysis of the association of tumor growth rate and overall and progression-free survival in metastatic non-small cell lung cancer (NSCLC) patients.
    Gong, Yutao
    Mason, Jeremy
    Shen, Yuan-Li
    Chang, Elaine
    Kazandjian, Dickran
    Blumenthal, Gideon Michael
    Singh, Harpreet
    Theoret, Marc Robert
    Tang, Shenghui
    Pazdur, Richard
    Beaver, Julia A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Correlation between progression-free and overall survival in a meta-analysis of aggregated survival data from patients with non-small cell lung cancer
    Aksenov, Sergey
    Lee, Daniel
    Edlund, Helena
    Minchella, Kaitlyn
    Xu, Hongmei
    Dunyak, James
    Al-Huniti, Nidal
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S63 - S64
12345